787 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Founders Financial Alliance LLC

Key Points

• Founders Financial Alliance LLC acquired 787 shares of Intuitive Surgical, valued at approximately $390,000, marking a new stake in the company.
• Intuitive Surgical reported a quarterly earnings per share (EPS) of $2.19, surpassing analyst estimates of $1.93, with a year-over-year revenue increase of 21.4%.
• Analysts' consensus rating for Intuitive Surgical is a "Moderate Buy," with a price target averaging $595.95 per share.

Founders Financial Alliance LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 787 shares of the medical equipment provider's stock, valued at approximately $390,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG raised its position in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after purchasing an additional 883 shares in the last quarter. Scotia Capital Inc. grew its stake in shares of Intuitive Surgical by 4.1% during the fourth quarter. Scotia Capital Inc. now owns 5,166 shares of the medical equipment provider's stock valued at $2,697,000 after buying an additional 204 shares during the last quarter. Kennedy Capital Management LLC grew its stake in shares of Intuitive Surgical by 14.7% during the fourth quarter. Kennedy Capital Management LLC now owns 13,094 shares of the medical equipment provider's stock valued at $6,835,000 after buying an additional 1,681 shares during the last quarter. Finally, Harbert Fund Advisors Inc. grew its stake in shares of Intuitive Surgical by 11.7% during the fourth quarter. Harbert Fund Advisors Inc. now owns 2,875 shares of the medical equipment provider's stock valued at $1,501,000 after buying an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Royal Bank Of Canada raised their target price on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 23rd. Citigroup reissued a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Finally, BTIG Research raised their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $6.34 during mid-day trading on Tuesday, reaching $478.19. The stock had a trading volume of 1,529,402 shares, compared to its average volume of 2,001,704. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a market cap of $171.42 billion, a PE ratio of 66.69, a price-to-earnings-growth ratio of 4.93 and a beta of 1.59. The company has a fifty day moving average price of $514.89 and a 200 day moving average price of $527.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the business earned $1.78 EPS. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,881 shares of company stock worth $7,920,634. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.